After presenting their research at our most recent MS researchXchange Live Event, Jessica Allanach and Dr. Marc Horwitz sat...
Month: June 2023
After presenting their research at our most recent MS researchXchange Live Event, Jessica Allanach and Dr. Marc Horwitz sat...
After presenting their research at our most recent MS researchXchange Live Event, Jessica Allanach and Dr. Marc Horwitz sat...
After laying out a controversial model for the role of EBV in MS, Gavin Giovannoni went a step further...
Early indications from CMSC suggest we are on the verge of major new options for MS treatment. Two signaling...
Biomarkers seemed to be everywhere at CMSC. Presenters discussed the great need for clinical assays that can provide a...
“Cross-reactive EBNA1 immunity targets alpha-crystallin B and is associated with multiple sclerosis.” Olivia G. Thomas, et al. – Karolinska...
Proteomic predictors of physical, cognitive and imaging outcomes in multiple sclerosis: 5-year follow-up study. DCI: 1.0. Kian Jalaleddini, et...
Large-scale cerebrospinal fluid proteomic analysis in Alzheimer’s disease patients reveals five molecular subtypes with distinct genetic risk profiles. DCI:...
“Sting and p53 DNA repair pathways are compromised in Alzheimer’s disease.” Thomas J. Nelson and Yunhui Xu – Marshall...